• Paul Ellis Marik


This chapter provides a brief overview on the management of patients following an accidental or a suicidal overdose. The reader is referred to toxicology texts and their local poison center for information on the management of specific intoxications.


Activate Charcoal Glycolic Acid Gastric Lavage Carbon Monoxide Poisoning Methanol Poisoning 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Watson WA, Litovitz TL, Klein-Schwartz W, et al. 2003 Annual report of the American Association of poison control centers toxic exposure surveillance system. Am J Emerg Med. 2004;22:335–404.Google Scholar
  2. 2.
    Pearce B, Grant IS. Acute liver failure following therapeutic paracetamol administration in patients with muscular dystrophies. Anaesthesia. 2008;63:89–91.PubMedCrossRefGoogle Scholar
  3. 3.
    Suchin SM, Wolf DC, Lee Y, et al. Potentiation of acetaminophen hepatotoxicity by phenytoin, leading to liver transplantation. Dig Dis Sci. 2005;50:1836–1838.PubMedCrossRefGoogle Scholar
  4. 4.
    Watkins PB, Kaplowitz N, Slattery JT, et al. Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial. JAMA. 2006;296:87–93.PubMedCrossRefGoogle Scholar
  5. 5.
    Larson AM, Polson J, Fontana RJ, et al. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology. 2005;42:1364–1372.PubMedCrossRefGoogle Scholar
  6. 6.
    Kuehn BM. FDA focuses on drugs and liver damage: labeling and other changes for acetaminophen. JAMA. 2009;302:369–371.PubMedCrossRefGoogle Scholar
  7. 7.
    Borman, MS. Organ-specific warnings; Internal Analgesic, Antipyretic, and Antirheumatic Drug Products for over the counter human use; Final Monograph. Available at: FDA-1977-N-0013. 2009. Department of Health and Human Services, Food and Drug administration. Accessed August 26, 2009.
  8. 8.
    Prescott LF, Illingworth RN, Critchley JA, et al. Intravenous N-acetylcysteine: the treatment of choice for paracetamol poisoning. Br Med J. 1979;2:1097–1100.PubMedCrossRefGoogle Scholar
  9. 9.
    Buckley NA, Whyte IM, O'Connell DL, et al. Oral or intravenous N-acetylcysteine: which is the treatment of choice for acetaminophen (paracetamol) poisoning? J Toxicol Clin Toxicol. 1999;37:759–767.PubMedCrossRefGoogle Scholar
  10. 10.
    Brent J. Current management of ethylene glycol poisoning. Drugs. 2001;61:979–988.PubMedCrossRefGoogle Scholar
  11. 11.
    Brent J, McMartin K, Phillips S, et al. Fomepizole for the treatment of ethylene glycol poisoning. N Engl J Med. 1999;340:832–838.PubMedCrossRefGoogle Scholar
  12. 12.
    Marzuk PM, Tardiff K, Leon AC, et al. Fatal injuries after cocaine use as a leading cause of death among young adults in New York City. N Engl J Med. 1995;332:1753–1757.PubMedCrossRefGoogle Scholar
  13. 13.
    Drug Abuse Warning Network, 2006: National Estimates of Drug-Related emergency Department Visits. Available at: http:// US Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Accessed August 8, 2009.
  14. 14.
    Shannon M. Clinical toxicity of cocaine adulterants. Ann Emerg Med. 1988;17:1243–1247.PubMedCrossRefGoogle Scholar
  15. 15.
    Hollander JE, Hoffman RS, Gennis P, et al. Prospective multicenter evaluation of cocaine-associated chest pain. Cocaine Associated Chest Pain (COCHPA) Study Group. Acad Emerg Med. 1994;1:330–339.PubMedCrossRefGoogle Scholar
  16. 16.
    McCord J, Jneid H, Hollander JE, et al. Management of cocaine-associated chest pain and myocardial infarction. A scientific statement from the American Heart Association acute cardiac care committee of the Council on Clinical Cardiology. Circulation. 2008;117:1897–1907.PubMedCrossRefGoogle Scholar
  17. 17.
    Weaver LK. Clinical practice. Carbon monoxide poisoning. N Engl J Med. 2009;360:1217–1225.PubMedCrossRefGoogle Scholar
  18. 18.
    Juurlink DN, Buckley N, Stanbrook MB, et al. Hyperbaric oxygen for carbon monoxide poisoning. Cochrane Database Syst Rev. 2005;CD002041.Google Scholar
  19. 19.
    Hyperbaric oxygen 2009; indications and results: The Hyperbaric Oxygen Therapy Committee report. Gesell, L. B. 2008. Durham, NC: Undersea and Hyperbaric Medical Society.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Division of Pulmonary and Critical Care MedicineEastern Virginia Medical SchoolNorfolkUSA

Personalised recommendations